| Financial Year |
March 31 2023 |
| Monetary Funds |
3,566,460,619.04 |
| Held-for-trading Financial Assets |
1,421,596,133.59 |
| Notes Receivable |
580,000.00 |
| Accounts Receivable |
625,463,027.24 |
| Advances to Suppliers |
21,638,193.44 |
| Other Receivables |
68,806,350.89 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
523,326,071.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
36,523,552.46 |
| Total Current Assets |
6,284,746,947.89 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
217,142,148.30 |
| Investment Properties |
57,044,261.31 |
| Fixed Assetes |
776,488,530.07 |
| Under-construction Projects |
572,513,036.14 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
357,458,184.86 |
| R&D expenses |
-- |
| Goodwill |
6,750,000.00 |
| Long-Term Deferred and Prepaid Expenses |
14,998,099.91 |
| Deferred Income Tax Assets |
89,297,740.86 |
| Other Non-Current Assets |
106,992,003.40 |
| Sub-Total of Non-Current Assets |
2,563,240,730.30 |
| Total Assets |
8,847,987,678.19 |
| Short-Term Loans |
243,219,286.45 |
| Trading Financial liabilities |
379,308.63 |
| Notes Payable |
-- |
| Accounts Payable |
776,889,373.88 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
142,643,168.29 |
| Taxes Payable |
114,768,941.28 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
429,372,497.83 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,965,168.02 |
| Other Current Liabilities |
691,861,083.62 |
| Sub-Total of Current Liabilities |
2,614,096,451.73 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,269,122.20 |
| Deferred Income Tax Liabilities |
1,490,804.33 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
26,220,397.09 |
| Total Liabilities |
2,640,316,848.82 |
| Paid-In Capital(Or Share Stock) |
754,210,692.00 |
| Capital Surplus |
917,642,029.21 |
| Surplus Reserve |
400,338,803.84 |
| LESS:Treasury Stock |
325,472,956.38 |
| Undistributed Profits |
4,369,105,399.84 |
| Minority Stockholder's Interest |
44,103,931.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,163,566,897.45 |
| Owner's Equity（Stockholder's Equity） |
6,207,670,829.37 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,847,987,678.19 |
